Searched for
AUROBINDO PHARMA LTD. ET
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
Flexi cap fund inflows halve to Rs 5,175 crore in May after record April. Is this profit booking or a buying opportunity?Flexi cap fund inflows dropped 49% in May to Rs 5,175 crore after April’s record surge, reflecting broader moderation across equity categor...
Bitcoin holds near $64,000 as falling oil prices and US-Iran peace hopes lift risk sentimentBitcoin hovered near $64,000, buoyed by falling oil prices and optimism for a US-Iran peace deal, which lifted overall risk sentiment. Whil...
HDFC Defence Fund adds Tata Motors, reduces exposure in MTAR Technologies and 1 other in MayHDFC Defence Fund added Tata Motors to its portfolio in May while trimming holdings in MTAR Technologies and Rishabh Instruments. The fund ...
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap playsIndian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page Industries i...
Laurence Balanco flags 5% downside risk for Nifty amid global yield surgeGlobal financial markets are experiencing a risk-off shift driven by rising sovereign bond yields, impacting equities and commodities. Mark...
Quant Mid Cap Fund exits Lenskart Solutions and 2 other stocks, adds SAIL in AprilQuant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund...
JioBlackRock Flexi Cap Fund exits 3 AMC stocks, HAL, and 13 others in AprilJioBlackRock Mutual Fund’s Flexi Cap Fund completely exited 17 stocks in April, including AMC companies and Hindustan Aeronautics, while ad...
Buy capital goods on dips, stay cautious on IT and consumption: Sudip BandyopadhyayMarket expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...
Buy Aurobindo Pharma Ltd. with target of Rs 1200: Mitesh Thacker"Aurobindo Pharma Ltd is a 'BUY' call with a target of Rs 1200 and a stop loss of Rs 1140."
- Buy Aurobindo Pharma Ltd with a target of Rs 960: Prakash Gaba
"Aurobindo Pharma Ltd is a 'BUY' call with a target of Rs 960 and stop loss of 917."
- Buy Aurobindo Pharma Ltd with a target of Rs 965: Ashwani Gujral
"Aurobindo Pharma Ltd is a 'BUY' call with a target of Rs 965 and stop loss of 730."
- Sell Aurobindo Pharma Ltd at a target of Rs 520: Mitesh Thacker
Sell Aurobindo Pharma Ltd with a target of Rs 520 for stoploss of Rs 551.
- Buy Aurobindo Pharma Ltd with a target of Rs 292: Ashwani Gujral
Buy Aurobindo Pharma Ltd with a target of Rs 292 and a stop loss of Rs 276.
- Buy Aurobindo Pharma with target of 186: Ashwani Gujral
Buy Aurobindo Pharma with a target of Rs 186 and a stop loss of Rs 174.